Rossari Biotech Share Price Today | Stock Price & Rossari Biotech Share Screener
As of October 5, 2026, the live Rossari Biotech share price (NSE: ROSSARI) is ₹430.90 on NSE and ₹430.55 on BSE, up 0.78% from the previous close, with shares trading between ₹417.80 and ₹435.90 in today's trading session, and a 52-week range of ₹378.60–₹653.10. Check ROSSARI annual price range for the annual price range and momentum. Use the Rossari Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Rossari Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹704 and net income of ₹46, with EBITDA of ₹97, an operating margin of 11.0% and a profit margin of 6.5%.
Rossari Biotech Share Price Chart
Track the current stock price of Rossari Biotech with an interactive chart. Analyse ROSSARI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Rossari Biotech stock quote in one place.
The quote of ₹430.90 sits between the 52-week low of ₹378.60 and the 52-week high of ₹653.10, and the latest session moved 0.78% from the previous close.
Rossari Biotech Company Profile - Fundamental Screener
Screen Rossari Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ROSSARI shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Specialty Chemicals industry, and it trades under ISIN INE02A801020.
Company Details
Classification
Identifiers and Leadership
Rossari Biotech Balance Sheet Screener
Screen ROSSARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹2,289, up from ₹1,896 in 2025.
Latest statistics put total assets at ₹2,289 and shareholder funds at ₹1,333, with a leverage ratio of 0.26.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 2,289 | 1,896 | 1,572 | 1,368 | 1,257 | 561 | 472 | 250 |
| Current Assets | 1,236 | 1,042 | 844 | 720 | 609 | 355 | 326 | 160 |
| Fixed Assets | 785 | 598 | 578 | 585 | 607 | 181 | 94 | 74 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 166 | 174 | 100 | 104 | 157 | 2 | 36 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 1,333 | 1,185 | 1,048 | 915 | 805 | 409 | 287 | 124 |
| Share Capital | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 4 |
| Reserves & Surplus | 1,322 | 1,174 | 1,037 | 904 | 794 | 398 | 277 | 119 |
Rossari Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Rossari Biotech income statement and profit fundamentals. Analyze ROSSARI quarterly results. Rossari Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹704 and net profit was ₹46, equal to earnings per unit of ₹8.30, at an operating margin of 11%.
In that period expenses were ₹608, interest cost ₹9 and tax ₹18. The next period listed, 2026-Jun, shows revenue of ₹701 and net profit of ₹35.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 704 | 701 | 582 | 545 | 588 | 583 | 473 | 491 | 499 | 514 | 410 | 413 | 485 | 467 | 442 |
| Expenses | 608 | 617 | 510 | 476 | 514 | 513 | 409 | 425 | 432 | 448 | 352 | 353 | 420 | 400 | 387 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 97 | 84 | 71 | 70 | 74 | 70 | 64 | 66 | 67 | 66 | 58 | 60 | 65 | 67 | 56 |
| Operating Profit % | 11.00% | 12.00% | 12.00% | 12.00% | 12.00% | 12.00% | 13.00% | 13.00% | 13.00% | 13.00% | 13.00% | 14.00% | 13.00% | 14.00% | 12.00% |
| Depreciation | 24 | 26 | 18 | 18 | 18 | 20 | 16 | 15 | 15 | 18 | 16 | 14 | 15 | 15 | 17 |
| Interest | 9 | 11 | 6 | 6 | 6 | 8 | 3 | 4 | 4 | 5 | 4 | 6 | 5 | 4 | 5 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 64 | 48 | 48 | 46 | 50 | 43 | 46 | 47 | 48 | 42 | 37 | 40 | 45 | 48 | 34 |
| Tax | 18 | 13 | 13 | 13 | 13 | 10 | 11 | 12 | 13 | 11 | 8 | 10 | 12 | 13 | 10 |
| Net Profit | 46 | 35 | 34 | 34 | 37 | 33 | 34 | 35 | 35 | 32 | 29 | 29 | 33 | 34 | 24 |
| EPS | 8.30 | 6.34 | 6.22 | 6.07 | 6.66 | 5.92 | 6.18 | 6.32 | 6.39 | 5.73 | 5.25 | 5.30 | 5.97 | 6.23 | 4.37 |
Rossari Biotech Cash Flow Screener - Liquidity Fundamentals
Screen ROSSARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹65, and net cash flow was an inflow of ₹31.
Over the same period, investing activities used ₹220 and financing activities provided ₹186.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | 65 | 137 | 43 | 152 | 29 | 48 | 57 | 71 |
| Investing Activities | -220 | -183 | -104 | -181 | -299 | -37 | -190 | -37 |
Financing and Net Cash | ||||||||
| Financing Activities | 186 | 65 | 16 | 61 | 292 | -25 | 157 | -29 |
| Net Cash Flow | 31 | 19 | -44 | 32 | 22 | -14 | 24 | 5 |
Rossari Biotech Shareholding Pattern Screener
See Rossari Biotech shareholding pattern with promoter, FII, and DII holdings. Check Rossari Biotech promoter holding and ownership changes for ROSSARI on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 68.15%, foreign institutions 2.18%, domestic institutions 18.20% and the public 10.11%, spread across 86,972 shareholders.
The shareholder count was 86,972 in 2026-Mar, compared with 87,580 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 68.15% | 68.14% | 68.18% | 68.17% | 68.17% | 68.16% | 68.32% | 68.32% |
Institutional Investors | ||||||||
| FII Holding | 2.18% | 2.02% | 3.98% | 3.48% | 2.69% | 2.33% | 4.03% | 3.83% |
| DII Holding | 18.20% | 14.64% | 17.59% | 17.84% | 18.18% | 18.26% | 17.75% | 16.87% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.11% | 13.39% | 9.20% | 9.44% | 9.47% | 9.89% | 9.14% | 9.96% |
| Other Holding | 1.35% | 1.80% | 1.05% | 1.07% | 1.48% | 1.37% | 0.76% | 1.02% |
| Shareholder Count | 86,972 | 87,580 | 92,852 | 91,791 | 91,387 | 89,249 | 98,859 | 100,475 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Rossari Biotech. Rossari Biotech dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.50 per unit for 2026-March, a yield of 0.11%, compared with ₹0.50 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.50, ₹0.50 and ₹0.50 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.50 | 0.11% |
| 2025-March | ₹0.50 | 0.13% |
| 2024-March | ₹0.50 | 0.08% |
| 2023-March | ₹0.50 | 0.07% |
| 2022-March | ₹0.50 | 0.08% |
| 2021-March | ₹0.50 | 0.05% |
| 2020-March | ₹0.50 | 0.05% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Rossari Biotech Stock Index Membership - Nifty & Sensex
See which indices include Rossari Biotech stock. Check ROSSARI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 5 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX CARBON, BSE INDEX SMLCAP, NIFTY MICROCAP250.
Complete Index List
Rossari Biotech Market Events Screener - Corporate Actions
Get Rossari Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Rossari Biotech stock events that may affect ROSSARI share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated July 20, 2026, with a record date of July 20, 2026.
It is followed by Quarterly Result Announcement dated July 18, 2026 and Dividend dated July 10, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-20 | 2026-07-20 | Annual General Meeting | NA | 3.56% |
| 2026-07-18 | 2026-07-18 | Quarterly Result Announcement | NA | 2.49% |
| 2026-07-10 | 2026-07-10 | Dividend | ₹ 0.50 /share | 0.27% |
| 2026-04-27 | 2026-04-27 | Quarterly Result Announcement | NA | 2.48% |
| 2026-01-17 | 2026-01-17 | Quarterly Result Announcement | NA | -5.38% |
| 2025-10-15 | 2025-10-15 | Quarterly Result Announcement | NA | 2.97% |
| 2025-07-19 | 2025-07-19 | Quarterly Result Announcement | NA | 6.09% |
| 2025-06-30 | 2025-06-30 | Annual General Meeting | NA | 2.20% |
| 2025-06-20 | 2025-06-20 | Dividend | ₹ 0.50 /share | -5.99% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | 2.48% |
| 2025-01-21 | 2025-01-21 | Quarterly Result Announcement | NA | -0.71% |
| 2024-11-11 | 2024-11-11 | Extraordinary General Meeting | NA | -6.62% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 2.55% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 13.57% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 0.50 /share | 18.00% |
Rossari Biotech Competitors Screener - Peer Stocks Comparison
Screen ROSSARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 148,697 | 57.06 | 14,867 | 11.05% | 2,471 | 28.51 |
| SRF | 71,738 | 34.14 | 15,894 | 7.20% | 1,835 | 32.14 |
| Gujarat Fluorochemicals | 48,402 | 81.29 | 5,126 | 5.63% | 574 | 39.67 |
| Navin Fluorine International | 42,223 | 54.80 | 3,379 | 41.21% | 664 | 44.76 |
| Himadri Speciality Chemical | 33,683 | 42.04 | 4,832 | 3.60% | 755 | 45.55 |
| Aether Industries | 23,223 | 97.93 | 1,181 | 34.17% | 220 | 64.86 |
| Deepak Nitrite | 20,855 | 27.00 | 7,947 | -5.01% | 551 | 32.35 |
| Atul | 17,614 | 21.76 | 6,476 | 13.77% | 689 | 33.40 |
| Aarti Industries | 17,038 | 32.54 | 8,291 | 13.78% | 419 | 37.04 |
| Fine Organic Industries | 15,759 | 35.83 | 2,483 | 4.89% | 417 | 50.29 |
Rossari Biotech Company Announcements - News & Reports Screener
Screen ROSSARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 2, 2026.
The next most recent announcements are dated September 16, 2026 and September 10, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-02 | Closure of Trading Window | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-06 | Update On Investor Call. | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-24 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-07-20 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-07-20 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-07-20 | Update On Grant Of Options. | - |
| 2026-07-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-19 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-18 | Intimation Under Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-07-18 | Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 2019 | - |
| 2026-07-18 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-07-18 | Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2026. | - |
| 2026-07-18 | Board Meeting Outcome for Outcome Of Board Meeting Held On July 18 2026. | - |
| 2026-07-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-10 | Board Meeting Intimation for Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹430.90, within a 52-week range of ₹378.60 to ₹653.10. The P/E ratio is 16.20 and the P/B ratio is 1.83, with earnings per unit of ₹26.95. Market capitalisation stands at ₹2,369.10 Cr and the dividend yield is 0.11%. The company operates in the Chemicals sector, in the Specialty Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.